152 related articles for article (PubMed ID: 37347441)
1. What Should be the Next Choice After Failure of Hormonal and Vigabatrin Therapy in Infantile Epileptic Spasms Syndrome?
Lal P; Sahu JK
Indian J Pediatr; 2023 Oct; 90(10):955-956. PubMed ID: 37347441
[No Abstract] [Full Text] [Related]
2. Response to sequential treatment with prednisolone and vigabatrin in infantile spasms.
Dzau W; Cheng S; Snell P; Fahey M; Scheffer IE; Harvey AS; Howell KB
J Paediatr Child Health; 2022 Dec; 58(12):2197-2202. PubMed ID: 36054157
[TBL] [Abstract][Full Text] [Related]
3. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective.
Ibrahim S; Gulab S; Ishaque S; Saleem T
BMC Pediatr; 2010 Jan; 10():1. PubMed ID: 20078871
[TBL] [Abstract][Full Text] [Related]
4. Vigabatrin Toxicity in a Patient with Infantile Spasms Treated with Concomitant Hormonal Therapy.
Lotan E; Bluvstein J; Zan E
Isr Med Assoc J; 2020 Jul; 22(7):461-462. PubMed ID: 33236576
[No Abstract] [Full Text] [Related]
5. Efficacy of vigabatrin in the treatment of infantile epileptic spasms syndrome: A systematic review and meta-analysis.
Xu Z; Gong P; Jiao X; Niu Y; Wu Y; Zhang Y; Chang X; Yang Z
Epilepsia Open; 2023 Jun; 8(2):268-277. PubMed ID: 36740237
[TBL] [Abstract][Full Text] [Related]
6. Adrenocorticotropic hormone versus prednisolone in the treatment of infantile spasms post vigabatrin failure.
Jones K; Snead OC; Boyd J; Go C
J Child Neurol; 2015 Apr; 30(5):595-600. PubMed ID: 24965788
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Cosyntropin, Vigabatrin, and Combination Therapy in New-Onset Infantile Spasms in a Prospective Randomized Trial.
Knupp KG; Coryell J; Singh RK; Gaillard WD; Shellhaas RA; Koh S; Mitchell WG; Harini C; Millichap JJ; May A; Dlugos D; Nickels K; Mytinger JR; Keator C; Yozawitz E; Singhal N; Lockrow J; Thomas JF; Juarez-Colunga E
J Child Neurol; 2022 Mar; 37(3):186-193. PubMed ID: 35044272
[No Abstract] [Full Text] [Related]
8. Vigabatrin-induced MRI changes associated with extrapyramidal symptoms in a child with infantile spasms.
Schonstedt V; Stecher X; Venegas V; Silva C
Neuroradiol J; 2015 Oct; 28(5):515-8. PubMed ID: 26306928
[TBL] [Abstract][Full Text] [Related]
9. Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.
O'Callaghan FJ; Edwards SW; Alber FD; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay M; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
Lancet Neurol; 2017 Jan; 16(1):33-42. PubMed ID: 27838190
[TBL] [Abstract][Full Text] [Related]
10. Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis.
Biswas A; Yossofzai O; Vincent A; Go C; Widjaja E
Expert Rev Neurother; 2020 Dec; 20(12):1315-1324. PubMed ID: 33078964
[No Abstract] [Full Text] [Related]
11. Vigabatrin administration in patients with infantile spasms: the risks.
Jaseja H
Clin Neurol Neurosurg; 2010 Nov; 112(9):835. PubMed ID: 20934097
[No Abstract] [Full Text] [Related]
12. Vigabatrin therapy for infantile spasms: review of major trials in Europe, Canada, and the United States; and recommendations for dosing.
Carmant L
Acta Neurol Scand Suppl; 2011; (192):36-47. PubMed ID: 22061179
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of vigabatrin in patients with infantile spasms.
Elterman RD; Shields WD; Mansfield KA; Nakagawa J;
Neurology; 2001 Oct; 57(8):1416-21. PubMed ID: 11673582
[TBL] [Abstract][Full Text] [Related]
14. What is the optimal duration for vigabatrin monotherapy in patients with infantile spasms: 6 months or longer?
Desnous B; Lenoir M; Bitton JY; Arbour M; Villeneuve N; Whiting S; Mohammed I; Wirrell EC; Bello-Espinosa L; Ronen GM; Lortie A; Birca A
Seizure; 2021 Oct; 91():503-506. PubMed ID: 34371246
[TBL] [Abstract][Full Text] [Related]
15. Vigabatrin for infantile spasms.
Pesaturo KA; Spooner LM; Belliveau P
Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
[TBL] [Abstract][Full Text] [Related]
16. Steroids or vigabatrin in the treatment of infantile spasms?
Riikonen RS
Pediatr Neurol; 2000 Nov; 23(5):403-8. PubMed ID: 11118795
[TBL] [Abstract][Full Text] [Related]
17. Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial.
O'Callaghan FJK; Edwards SW; Alber FD; Cortina Borja M; Hancock E; Johnson AL; Kennedy CR; Likeman M; Lux AL; Mackay MT; Mallick AA; Newton RW; Nolan M; Pressler R; Rating D; Schmitt B; Verity CM; Osborne JP;
Lancet Child Adolesc Health; 2018 Oct; 2(10):715-725. PubMed ID: 30236380
[TBL] [Abstract][Full Text] [Related]
18. Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent.
Hussain SA; Tsao J; Li M; Schwarz MD; Zhou R; Wu JY; Salamon N; Sankar R
Epilepsia; 2017 Apr; 58(4):674-682. PubMed ID: 28230253
[TBL] [Abstract][Full Text] [Related]
19. Are vigabatrin induced T2 hyperintensities in cranial MRI associated with acute encephalopathy and extrapyramidal symptoms?
Dill P; Datta AN; Weber P; Schneider J
Eur J Paediatr Neurol; 2013 May; 17(3):311-5. PubMed ID: 23199677
[TBL] [Abstract][Full Text] [Related]
20. Treatment of West syndrome with vigabatrin: reversible MRI signal changes.
Carvalho Neto Ad; Coelho LO; Ono SE; Crippa AC
Arq Neuropsiquiatr; 2011 Dec; 69(6):998. PubMed ID: 22297900
[No Abstract] [Full Text] [Related]
[Next] [New Search]
